Varian

Varian Medical Systems, acquired by Siemens Healthineers in 2021 for $16.4 billion, provides specialized oncology information systems centered around its ARIA Oncology Information System platform. The company serves radiation oncology departments, medical oncology practices, cancer centers, and academic medical institutions worldwide, with systems installed in over 10,000 treatment centers across more than 140 countries.

ARIA serves as Varian's flagship EMR/OIS platform, designed specifically for comprehensive cancer care management. The system integrates radiation therapy planning, medical oncology treatment management, chemotherapy ordering with dose calculation and verification, clinical trials management, and tumor registry integration. ARIA's core strength lies in its native integration with Varian's radiation therapy equipment including TrueBeam, Halcyon, and ProBeam systems, enabling closed-loop treatment delivery where treatment plans automatically transfer to delivery systems with built-in safety checks and dose verification.

The platform differentiates itself through deep radiation oncology functionality including advanced dose calculation algorithms, machine-specific quality assurance protocols, and real-time treatment verification. ARIA supports multi-disciplinary cancer care through integrated tumor board documentation, chemotherapy protocol libraries with NCCN guideline integration, and survivorship care planning tools. The system manages clinical trial workflows including patient eligibility screening, protocol compliance tracking, and adverse event reporting.

Varian's deployment model is typically on-premises for larger cancer centers, though cloud-based options have become available through Siemens Healthineers infrastructure. The system targets medium to large radiation oncology departments (typically 2+ linear accelerators), comprehensive cancer centers, and academic medical institutions. Implementation timelines typically range from 6-18 months depending on scope and integration requirements.

Key technical capabilities include DICOM-RT compliance for radiation therapy data exchange, HL7 integration for EMR connectivity, and IHE radiation oncology profiles for interoperability. ARIA integrates with major EMR systems including Epic, Cerner, and MEDITECH through bidirectional interfaces for patient demographics, lab results, and clinical documentation. The platform supports multi-site deployments with centralized reporting and analytics through ARIA Analytics.

Varian's market position as part of Siemens Healthineers provides access to broader enterprise imaging infrastructure and cross-continental support networks. The system competes primarily with Elekta MOSAIQ and RaySearch RayCare in the radiation oncology OIS space. Varian's installed base and equipment integration create significant switching costs, with most customers maintaining long-term relationships spanning decades. The platform's weakness lies in medical oncology functionality compared to specialized chemotherapy EMRs, though it provides adequate coverage for integrated cancer centers requiring unified radiation and medical oncology workflows.